thiophenes has been researched along with Affective Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Choe, HK; Choe, Y; Choi, JW; Choi, M; Jang, S; Kim, D; Kim, J; Kim, K; Moon, C; Park, I; Park, SH; Sun, W | 1 |
| Antonini, A; Brown, RG; Friedman, JH; Ghys, L; Martinez-Martin, P; Onofrj, M; Ray Chaudhuri, K; Surmann, E; Trenkwalder, C | 1 |
| Chapman, PF; Hirano, K; Miller, ND; Piers, TM; Rutter, AR; Searle, KL | 1 |
| Brecht, S; Crucitti, A; Nilsson, M; Wernicke, J; Yang, CR; Zhang, Q | 1 |
| Dundon, K; Mease, PJ; Sarzi-Puttini, P | 1 |
| Bailey, KP | 1 |
3 review(s) available for thiophenes and Affective Disorders
| Article | Year |
|---|---|
Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis.
Topics: Antidepressive Agents; Anxiety Disorders; Blood Glucose; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Glycemic Index; Humans; Hyperglycemia; Male; Middle Aged; Mood Disorders; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome | 2010 |
Pharmacotherapy of fibromyalgia.
Topics: Analgesics; Chronic Pain; Clinical Trials as Topic; Cognition Disorders; Cyclopropanes; Duloxetine Hydrochloride; Fatigue; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Mood Disorders; Pain Management; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Syndrome; Thiophenes; Treatment Outcome | 2011 |
Physical symptoms comorbid with depression and the new antidepressant duloxetine.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder; Duloxetine Hydrochloride; Gastrointestinal Diseases; Humans; Mood Disorders; Norepinephrine; Pain; Psychophysiologic Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin; Sleep Wake Disorders; Thiophenes; Treatment Outcome | 2003 |
1 trial(s) available for thiophenes and Affective Disorders
| Article | Year |
|---|---|
Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Analysis of Variance; Apathy; Dopamine Agonists; Dose-Response Relationship, Drug; Fatigue; Female; Humans; Male; Middle Aged; Mood Disorders; Parkinson Disease; Psychiatric Status Rating Scales; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes | 2013 |
2 other study(ies) available for thiophenes and Affective Disorders
| Article | Year |
|---|---|
Pharmacological Rescue with SR8278, a Circadian Nuclear Receptor REV-ERBĪ± Antagonist as a Therapy for Mood Disorders in Parkinson's Disease.
Topics: Animals; Humans; Isoquinolines; Mice; Mood Disorders; Neurodegenerative Diseases; Nuclear Receptor Subfamily 1, Group D, Member 1; Oxidopamine; Parkinson Disease; Quality of Life; Thiophenes; Tyrosine 3-Monooxygenase | 2022 |
Procognitive 5-HT6 antagonists in the rat forced swimming test: potential therapeutic utility in mood disorders associated with Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Behavior, Animal; Cognition; Male; Mood Disorders; Piperazines; Protein Binding; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists; Sulfonamides; Swimming; Thiophenes | 2009 |